The company has merged technology and health care to create a digital ecosystem for the promotion of health and wellbeing. Their efforts will be presented to the global tech community by Marko Bitenc, the company’s CEO.
As a global biotech company, GenePlanet is always on the lookout for opportunities to present how it utilizes gene testing to positively impact people's lives. To that end the company will be attending Collision, North America's fastest growing technological conference, held between May 20 and 23 at Toronto's Enercare Centre.
Collision returns for its fifth year with estimated 25,000 attendees, more than 120 participating countries, top management of the world's biggest companies and most promising startups, as well as investors searching for groundbreaking solutions. It is an event which will undoubtedly set new standards and expand technological frontiers.
In Toronto, GenePlanet’s CEO and founder Marko Bitenc will be among more than 500 speakers, joining the likes of Peggy Johnson, Executive Vice President at Microsoft, David Eun, Chief Innovation Officer at Samsung Electronics, and Palmer Luckey, Founder at Oculus VR. Bitenc will share intriguing insight into genetic testing by presenting Health Intelligence platform and whole genome sequencing.
Whole genome sequencing is a process of analyzing and determining the entire DNA sequence of an individual’s genome. This data has great potential in disease prevention and personalized medicine, and GenePlanet is among the first to start utilizing it.
Health Intelligence platform is GenePlanet’s innovative approach at merging biological data with the information obtained from smart devices. Input from genetic and blood tests, smartphone apps, smartwatches, and other wearable tracking devices, presents actionable information for the Health Intelligence system. The platform analyzes this data and offers recommendations and action plans for improving an individual's health and overall quality of life. Because it is so highly personalized it provides users with the best possible tools for achieving significant changes in their lifestyle, which in turn leads to a healthier life with considerably fewer risks for developing serious diseases.
Not only a biotech company, present in over 30 countries globally, GenePlanet is also among the 1000 fastest growing companies in Europe. And according to Bitenc, that growth will continue: »In the next couple of years we are planning an expansion to North America. « The upcoming Collision conference will provide the perfect opportunity to interact with the market, meet potential partners and investors, and mostly, present GenePlanet’s life-improving gene testing solutions to the North American market.